logoTry Persana

Eugit Therapeutics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Eugit Therapeutics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Eugit Therapeutics company logo

Tissue targeting of therapies

Eugit Therapeutics focuses on tissue targeting technology for immune-mediated diseases.

HeadquartersSan Carlos, United States
Team size1-10
Founded2022

What is Eugit Therapeutics? - Company Overview & Details

Eugit Therapeutics is Eugit Therapeutics focuses on tissue targeting technology for immune-mediated diseases. Founded in 2022, the company is headquartered in San Carlos, United States.

Who Founded Eugit Therapeutics?

Eugit Therapeutics was founded by George Church.

Who are the Key Executives at Eugit Therapeutics? - Leadership Team

Eugit Therapeutics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Eugit Therapeutics

George ChurchCEO

Chief Technology Officer (CTO) of Eugit Therapeutics

CTO

About George Church - CEO of Eugit Therapeutics

George Church serves as the Chief Executive Officer of Eugit Therapeutics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Eugit Therapeutics Company Details & Key Information

Where is Eugit Therapeutics located?

Eugit Therapeutics is headquartered in San Carlos, United States.

How many employees does Eugit Therapeutics have?

Eugit Therapeutics has 1-10 employees.

When was Eugit Therapeutics founded?

Eugit Therapeutics was founded in 2022.

Eugit Therapeutics Official Website

How much funding has Eugit Therapeutics raised?

Eugit Therapeutics has raised $500,000 across 1 funding rounds. The most recent funding was completed on 2022-10-08.

Funding Overview

Eugit Therapeutics has raised a total of $500,000 in pre-seed funding led by Y Combinator.

$500,000
Total Funding Raised
1
Funding Rounds
2022-10-08
Latest Round

Eugit Therapeutics Funding History

Pre seed
2022-10-08
$500,000

Who are the key investors in Eugit Therapeutics?

Eugit Therapeutics is backed by 1 key investors including Y Combinator. These investors focus on Biotechnology, Therapeutics sectors.

Eugit Therapeutics Investor Overview

1
Key Investors
2
Focus Areas
1
Notable Investments

Complete List of Eugit Therapeutics Investors

Y Combinator

A well-known startup accelerator.

Investment Focus
Biotechnology
Therapeutics
Notable Portfolio Companies
Eugit Therapeutics

What sectors do Eugit Therapeutics investors focus on?

The investors backing Eugit Therapeutics primarily focus on Biotechnology, Therapeutics sectors.

Biotechnology
Therapeutics

Featured Investor: Y Combinator

Y Combinator

A well-known startup accelerator.

Notable Investments: Eugit Therapeutics

What are Eugit Therapeutics's future plans?

Eugit Therapeutics Eugit Therapeutics aims to advance its tissue targeting technology and explore further funding opportunities.

Eugit Therapeutics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Eugit Therapeutics face?

Eugit Therapeutics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Eugit Therapeutics

1

Securing additional funding

2

Regulatory approvals

What opportunities does Eugit Therapeutics have?

Eugit Therapeutics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Eugit Therapeutics

1

Expansion into new markets

2

Partnerships with research institutions

Eugit Therapeutics Strategic Position Summary

Key Focus Areas

Eugit Therapeutics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Eugit Therapeutics?

Eugit Therapeutics has 2 recent news updates covering key business developments and market activities.

Eugit Therapeutics News Overview

2
Recent Articles
Active
Media Coverage
2024-08-19
Latest Update

What is Eugit Therapeutics in the news for?

Eugit Therapeutics is currently featured in news for Eugit Therapeutics awarded NSF Phase 1 grant and other significant business developments.

Recent News Articles About Eugit Therapeutics

Article 1
2024-08-19

Eugit Therapeutics awarded NSF Phase 1 grant

Eugit Therapeutics has been awarded an NSF Phase 1 grant for its tissue targeting technology.

Read News
Article 2

Read News

Eugit Therapeutics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Eugit Therapeutics including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Eugit Therapeutics Questions & Answers - Company Information

Q1

What is Eugit Therapeutics?

Eugit Therapeutics focuses on tissue targeting technology for immune-mediated diseases.

Q2

Who founded Eugit Therapeutics?

Eugit Therapeutics was founded by George Church.

Q3

Who is the CEO of Eugit Therapeutics?

The CEO of Eugit Therapeutics is George Church. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Eugit Therapeutics raised?

Eugit Therapeutics has raised a total of $$500,000 across 1 funding rounds. The most recent funding was completed on 2022-10-08.

Q5

Who are the investors in Eugit Therapeutics?

Eugit Therapeutics's key investors include Y Combinator.

Q6

Where is Eugit Therapeutics headquartered?

Eugit Therapeutics is headquartered in San Carlos, United States.

Q7

When was Eugit Therapeutics founded?

Eugit Therapeutics was founded in 2022.

Q8

How many employees does Eugit Therapeutics have?

Eugit Therapeutics has 1-10 employees.

Q9

What is Eugit Therapeutics's official website?

You can visit Eugit Therapeutics's official website at Www.eugittx.com.

Q10

What was Eugit Therapeutics's latest funding round?

Eugit Therapeutics's latest funding round was a Pre seed round of $$500,000 completed on 2022-10-08.

Q11

Who is founder?

George Church

Q12

What does the company do?

Eugit Therapeutics focuses on tissue targeting technology for immune-mediated diseases.

Q13

How much funding?

$500,000

Q14

Latest funding date?

2022-10-08

Q15

Who are the investors?

Y Combinator

Q16

What are the challenges?

Securing additional funding Regulatory approvals

Q17

What are the opportunities?

Expansion into new markets Partnerships with research institutions

Q18

Latest news?

Eugit Therapeutics has been awarded an NSF Phase 1 grant for its tissue targeting technology.

More Information About Eugit Therapeutics

For additional details about Eugit Therapeutics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.